iBio, Inc.
IBIO · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,377 | -$24,907 | -$65,010 | -$29,512 |
| Dep. & Amort. | $291 | $1,250 | $1,380 | $3,791 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,530 | $2,038 | $4,391 | $0 |
| Change in WC | $479 | -$3,168 | $5,869 | $3,243 |
| Other Non-Cash | $773 | $6,233 | $22,934 | -$15,324 |
| Operating Cash Flow | -$15,304 | -$18,554 | -$30,436 | -$37,802 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16 | -$210 | -$5,738 | -$11,630 |
| Net Acquisitions | $0 | $0 | -$692 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$7,115 |
| Inv. Sales/Matur. | $0 | $0 | $10,839 | $13,618 |
| Other Inv. Act. | $758 | $1,116 | $2,600 | $0 |
| Investing Cash Flow | $742 | $906 | $7,009 | -$5,127 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$771 | -$1,138 | -$9,125 | -$5,830 |
| Stock Issued | $9,700 | $25,523 | $11,487 | $77 |
| Stock Repurch. | $0 | -$7 | -$39 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $116 | -$22 | -$50 |
| Financing Cash Flow | $8,929 | $24,494 | $2,301 | -$5,803 |
| Forex Effect | $0 | $0 | $33 | -$5,996 |
| Net Chg. in Cash | -$5,633 | $6,846 | -$21,093 | -$54,728 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,425 | $7,579 | $28,672 | $77,404 |
| End Cash | $8,792 | $14,425 | $7,579 | $22,676 |
| Free Cash Flow | -$15,320 | -$18,764 | -$36,174 | -$45,132 |